Novel Blockers of the Renin-Angiotensin-Aldosterone System in Chronic Heart Failure

Archyut Valluri; Allan D. Struthers; Chim C Lang

doi:10.1007/s11897-013-0173-5

Novel Blockers of the Renin-Angiotensin-Aldosterone System in Chronic Heart Failure

Archyut Valluri, Allan D. Struthers, Chim C Lang (Lead / Corresponding author)

Research output: Contribution to journal › Article › peer-review

3 Citations (Scopus)

Abstract

Because of the impressive record of ACE inhibitors in patients with heart failure with reduced ejection fraction, the renin-angiotensin-aldosterone system continues to be pursued as a therapeutic target. Furthermore, the optimal treatment of patients with heart failure with preserved ejection fraction remains unclear. Early trials of direct renin inhibitors suggested that they may have a role, but recent results have not been encouraging. Preliminary trials of angiotensin-receptor/neprilysin inhibitors look positive. Whether these or other drugs will alter current recommendations remains to be seen.

Original language	English
Journal	Current Heart Failure Reports
DOIs	https://doi.org/10.1007/s11897-013-0173-5
Publication status	Published - Nov 2013

Access to Document

10.1007/s11897-013-0173-5

Cite this

@article{b688a0aad42a40b0b25c3d4af8084edb,

title = "Novel Blockers of the Renin-Angiotensin-Aldosterone System in Chronic Heart Failure",

abstract = "Because of the impressive record of ACE inhibitors in patients with heart failure with reduced ejection fraction, the renin-angiotensin-aldosterone system continues to be pursued as a therapeutic target. Furthermore, the optimal treatment of patients with heart failure with preserved ejection fraction remains unclear. Early trials of direct renin inhibitors suggested that they may have a role, but recent results have not been encouraging. Preliminary trials of angiotensin-receptor/neprilysin inhibitors look positive. Whether these or other drugs will alter current recommendations remains to be seen.",

author = "Archyut Valluri and Struthers, {Allan D.} and Lang, {Chim C}",

year = "2013",

month = nov,

doi = "10.1007/s11897-013-0173-5",

language = "English",

journal = "Current Heart Failure Reports",

issn = "1546-9530",

publisher = "Current Science, Inc.",

}

TY - JOUR

T1 - Novel Blockers of the Renin-Angiotensin-Aldosterone System in Chronic Heart Failure

AU - Valluri, Archyut

AU - Struthers, Allan D.

AU - Lang, Chim C

PY - 2013/11

Y1 - 2013/11

N2 - Because of the impressive record of ACE inhibitors in patients with heart failure with reduced ejection fraction, the renin-angiotensin-aldosterone system continues to be pursued as a therapeutic target. Furthermore, the optimal treatment of patients with heart failure with preserved ejection fraction remains unclear. Early trials of direct renin inhibitors suggested that they may have a role, but recent results have not been encouraging. Preliminary trials of angiotensin-receptor/neprilysin inhibitors look positive. Whether these or other drugs will alter current recommendations remains to be seen.

AB - Because of the impressive record of ACE inhibitors in patients with heart failure with reduced ejection fraction, the renin-angiotensin-aldosterone system continues to be pursued as a therapeutic target. Furthermore, the optimal treatment of patients with heart failure with preserved ejection fraction remains unclear. Early trials of direct renin inhibitors suggested that they may have a role, but recent results have not been encouraging. Preliminary trials of angiotensin-receptor/neprilysin inhibitors look positive. Whether these or other drugs will alter current recommendations remains to be seen.

U2 - 10.1007/s11897-013-0173-5

DO - 10.1007/s11897-013-0173-5

M3 - Article

C2 - 24234398

SN - 1546-9530

JO - Current Heart Failure Reports

JF - Current Heart Failure Reports

ER -

Novel Blockers of the Renin-Angiotensin-Aldosterone System in Chronic Heart Failure

Abstract

Access to Document

Fingerprint

Cite this